| Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system M Punekar, M Kshirsagar, C Tellapragada, K Patil Microbial Pathogenesis 168, 105608, 2022 | 14 | 2022 |
| A transcriptomics-based bioinformatics approach for identification and in vitro screening of FDA-approved drugs for repurposing against dengue virus-2 M Punekar, B Kasabe, P Patil, MB Kakade, D Parashar, K Alagarasu, ... Viruses 14 (10), 2150, 2022 | 6 | 2022 |
| Drug repurposing approach against chikungunya virus: an in vitro and in silico study B Kasabe, G Ahire, P Patil, M Punekar, KS Davuluri, M Kakade, ... Frontiers in Cellular and Infection Microbiology 13, 1132538, 2023 | 4 | 2023 |
| Effect of carpaine, a major alkaloid from Carica papaya leaves, on dengue virus‐2 infection and replication‐an in‐vitro and in‐silico study K Alagarasu, M Punekar, P Patil, B Kasabe, M Kakade, KS Davuluri, ... Phytotherapy Research 37 (8), 3191-3194, 2023 | 3 | 2023 |
| Synthesis of novel rhodamine type Anthrone Spiro-lactam (ASL) analogues and evaluation of antiviral activity against dengue and chikungunya viruses RS Darole, PK Bagad, RG Gonnade, K Alagarasu, M Punekar, S Shukla, ... European Journal of Medicinal Chemistry 261, 115849, 2023 | | 2023 |
| Understanding the resurgence of chikungunya virus during 2020− 2021 in Pune, India, based on genomic analyses: A seven year study K Alagarasu, J Patil, S Jadhav, D Chowdhury, M Bote, M Punekar, A More, ... Journal of Medical Virology 95 (11), e29253, 2023 | | 2023 |
| Corrigendum: Drug repurposing approach against chikungunya virus: an in vitro and in silico study B Kasabe, G Ahire, P Patil, M Punekar, KS Davuluri, M Kakade, ... Frontiers in Cellular and Infection Microbiology 13, 1226054, 2023 | | 2023 |
